Archive

Colombian ivermectin study – how protocol violations influenced results

Written by | 26 Mar 2021

The results of the recent controlled trial of ivermectin for covid-19 in Colombia suggest that both ivermectin and control groups received ivermectin, according to Dr David Scheim. https://www.youtube.com/watch?v=T67szXgTqWw&ab_channel=MedicalUpdateOnline […]

Protocol violations in Colombian ivermectin study compromise results

Written by | 25 Mar 2021

Dr David Scheim explains how multiple protocol violations and widespread use of over-the-counter ivermectin could have compromised the results of a recent controlled trial of ivermectin for covid-19 […]

Ivermectin in Peru – results that save lives

Written by | 24 Mar 2021

Dr David Scheim explains how the original analysis factored out confounders and showed a 74% reduction in deaths at 30 days as a result of intensive ivermectin distribution. […]

Analysis confirms 14 fold reduction in deaths with Ivermectin treatment in Peru

Written by | 23 Mar 2021

Further analysis of results from Peru has now shown that systematic treatment of the population for covid-19 with ivermectin resulted in a 14-fold reduction in excess deaths. IMI interviewed Dr […]

Ivermectin mass treatment in perspective

Written by | 17 Feb 2021

Ivermectin is a good treatment to use interim to and complementary to immunisations, according to Dr David Scheim, one of the authors of a study of mass treatment for covid-19 […]

Ivermectin dosing and distribution for mass treatment

Written by | 16 Feb 2021

Dr David Scheim, one of the authors of a recent study in Peru, describes the doses of ivermectin that were used and the strategies for effective mass distribution. https://www.youtube.com/watch?v=MSkKU18VlNo […]

Results of using ivermectin for mass treatment

Written by | 15 Feb 2021

Mature, real world data on systematic mass treatment of covid-19 with ivermectin show a sharp fall in excess deaths. IMI interviewed Dr David Scheim, one of the authors […]

Ivermectin gathers pace in Europe

Written by | 31 Jan 2021

During the past week Slovakia became the first European country to give formal approval for the use of ivermectin for both prophylaxis and treatment of covid-19 patients. Ivermectin […]

Extra doses of COVID-19 vaccine approved

Written by | 13 Jan 2021

The European Medicines Agency (EMA) has confirmed that health authorities can extract six doses of vaccine from each vial of Comirnaty, a vaccine against COVID-19 manufactured by Pfizer/BioNTech. […]

TB vaccine linked to lower risk of contracting COVID-19

Written by | 24 Dec 2020

A widely used tuberculosis vaccine is associated with reduced likelihood of contracting COVID-19 (coronavirus), according to a new study by Cedars-Sinai. The findings raise the possibility that a vaccine already […]

Vaccines – getting the message across

Written by | 28 Nov 2020

Knowing that your GP or pharmacist has had the vaccine can be deeply reassuring, according to Gary Finnegan, health journalist and Editor of Vaccines Today. When communicating about […]

Vaccine confidence and hesitancy

Written by | 27 Nov 2020

Understanding the three Cs of vaccine hesitancy could be the key to ensuring effective uptake of covid-19 vaccines, according to Gary Finnegan, health journalist and Editor of Vaccines […]

Newsletter Icon

Sign up to our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Sign Up

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.